Impact of sequential administration of detomidine, butorphanol, and midazolam on sedation, ataxia, stimulus response, and bispectral index in horses.
Authors: Thorn Caitlin A, Wilson Deborah V, Wang Sichao, Horne William A
Journal: Frontiers in veterinary science
Summary
# Editorial Summary Achieving reliable standing sedation in horses requires balancing adequate stimulus suppression against unwanted effects such as ataxia and collapse, prompting investigation into whether lower-dose polypharmacy might improve safety margins compared to single-agent protocols. Thorn and colleagues administered sequential injections of detomidine, butorphanol, and midazolam to standing horses, evaluating sedation depth, incoordination, responsiveness to noxious stimuli, and bispectral index (BIS) values throughout the procedure. The combination produced dose-dependent sedation without triggering recumbency; notably, BIS readings showed a linear correlation with clinical sedation scores and stimulus response thresholds, suggesting BIS monitoring could become a practical objective measure of sedation adequacy in equine practice. For farriers and veterinarians performing routine procedures such as dental work, this protocol offers a framework for using reduced individual doses whilst maintaining procedure safety, though the clinical utility of real-time BIS monitoring will depend on equipment availability and cost-effectiveness in field settings. These findings warrant further evaluation in actual procedural contexts to confirm whether this pharmacological approach and monitoring strategy translates into improved clinical outcomes with reduced complication rates.
Read the full abstract on PubMed
Practical Takeaways
- •Consider combining detomidine, butorphanol, and midazolam at reduced individual doses for standing procedures like dental work—this multi-agent approach may provide better sedation quality and safety margins than traditional single-drug protocols
- •Midazolam addition to standard sedative combinations may improve procedural control without increasing ataxia risk, making it useful for procedures requiring patient cooperation
- •BIS monitoring can be a useful adjunct to clinical observation for assessing sedation depth in standing horses, helping prevent both inadequate sedation and over-sedation
Key Findings
- •Sequential administration of detomidine, butorphanol, and midazolam provides effective standing sedation in horses with improved stimulus response blocking
- •Lower doses of multiple agents in combination minimize adverse effects including ataxia and recumbency compared to single-agent protocols
- •Bispectral index (BIS) monitoring shows correlation with clinical sedation scores in horses, similar to human ICU applications